Emergency Medical Research Journals

Emergency Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sandborn WJ et al. - Ustekinumab induced a clinical response in patients with moderate-to-severe Crohn's disease, especially in patients previously given infliximab.

Related Articles

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis
British Journal of Dermatology, 11/13/09    Relevance Score: 84%%

Ustekinumab for the treatment of plaque psoriasis
Expert Review of Dermatology, 10/13/09    Relevance Score: 84%%

FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09    Relevance Score: 82%%

Today in Clinical Pharmacology...keeping you current

Propylene Glycol Accumulation in Critically Ill Patients Receiving Continuous Intravenous Lorazepam Infusions
Annals of Pharmacotherapy, 11/25/09

Pharmacotherapy for acute pancreatitis
Expert Opinion in Pharmacotherapy, 11/24/09

Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
Archives of Drug Information, 11/24/09

Today in GI/Abdominal...keeping you current

Death Due to Hemorrhagic Shock After Delayed Rupture of Spleen: A Rare Phenomenon
American Journal of Forensic Medicine and Pathology, 11/25/09

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load
Case Reports in Gastroenterology, 11/25/09

Pharmacotherapy for acute pancreatitis
Expert Opinion in Pharmacotherapy, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address